Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label platinum sensitive. Show all posts
Showing posts with label platinum sensitive. Show all posts
Thursday, May 24, 2012

Eribulin: A Novel Cytotoxic Chemotherapy Agent (June).

›
Eribulin: A Novel Cytotoxic Chemotherapy Agent (June) Ann Pharmacother. 2012 May 22; Abstract OBJECTIVE :To review the chemistry, ph...
Tuesday, April 24, 2012

open access: JCO - OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

›
OCEANS : A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Plati...
Tuesday, March 27, 2012

open access: Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM

›
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM ......"We evaluated the efficacy of olaparib monoth...

Morphotek®, Inc. Announces Completion of Enrollment in the FAR-131 Trial for Relapsed Ovarian Cancer

›
Morphotek®, Inc. Announces Completion of Enrollment in the FAR-131 Trial for Relapsed... -- EXTON, Pa., March 27, 2012 /PRNewswire/ -- Cl...
Monday, February 13, 2012

abstract: Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

›
Objective To evaluate the predictive power of serum CA-125 changes in the management of patients under going neoadjuvant chemotherapy fol...
Tuesday, June 07, 2011

Sanofi preps for new pivotal trial of a blockbuster hopeful - Iniparib/phase 11/platinum sensitive

›
Sunday, August 15, 2010

Chemotherapy Options in the Management of Platinum-Sensitive Recurrent Ovarian Cancer

›
Note: registration required to view (free) SPECIAL EDITION / EDUCATIONAL REVIEWS ...
Tuesday, May 25, 2010

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

›
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer...
Thursday, April 29, 2010

Clinical Update - Ovarian Cancer (commentary - Australia)- Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer ...

›
Note: abstract plus commentary from Australian specialist/Associate Professor Jim Nicklin; includes reference to upcoming trial results
Tuesday, April 13, 2010

Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cance

›
A bstract PURPOSE: The goal of this study was to evaluate the outcomes and response in a cohort of patients with presumed platinum-se...